Publication List – Jin Li
Maguy A, Tardif JC, Busseuil D, Ribi C, Li J**. Autoantibody signature in cardiac arrest. Circulation 2020;141:1764-1774. doi: 10.1161/CIRCULATIONAHA.119.044408
Maguy A, Kucera JP, Wepfer JP, Forest V, Charpentier F, Li J**. KCNQ1 antibodies for immunotherapy of long QT syndrome type 2. J Am Coll Cardiol 2020;75:2140-52.
Li J, Wyrsch D, Hek D, Stoller M, Zanchin T, Perrin T, Windecker S, Räber L, Roten L. Electrocardiographic predictors of mortality in patients after percutaneous coronary interventions – a nested case-control study. Acta Cardiol 2018. DOI: 10.1080/00015385.2018.1494117.
Li J**, Maguy A. Autoimmune channelopathies: questions remain. Nat Rev Cardiol 2017; doi: 10.1038/nrcardio.2017.110.
Lettino M, Andell P, Zeymer U, Widimsky P, Danchin N, Bardaji A, Barrabes JA, Cequier A, Claeys MJ, De Luca L, Dörler J, Erlinge D, Eme P, Goldstein P, Koul SM, Lemesle G, Lüscher TF, Matter CM, Montalescot G, Radovanovic D, Sendón JL, Tousek P, Weidinger F, Weston CF, Zaman A, Li J, Jumeka JW; PIRAEUS group. Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes. Eur Heart J Cardiovasc Pharmacother 2017;3:198-213.
Zeymer U, Widimsky P, Danchin N, Lettino M, Bardaji A, Barrabes JA, Cequier A, Claeys MJ, De Luca L, Dörler J, Erlinge D, Erne P, Goldstein P, Koul SM, Lemesle G, Lüscher TF, Matter CM, Montalescot G, Radovanovic D, Sendón JL, Tousek P, Weidinger F, Weston CFM, Zaman A, Andell P, Li J, Jukema JW, on behalf of the PIRAEUS group. P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries. Eur Heart J Cardiovasc Pharmacother 2016; 2:229-43.
Danchin D, Lettino M, Zeymer U, Widimsky P, Bardaji A, Barrabes JA, Cequier A, Claeys MJ, De Luca L, Dörler J, Erlinge D, Erne P, Goldstein P, Koul SM, Lemesle G, Lüscher TF, Matter CM, Montalescot G, Radovanovic D, Sendón JL, Tousek P, Weidinger F, Weston CFM, Zaman A, Andell P, Li J, Jukema JW, on behalf of the PIRAEUS group. Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries. Eur Heart J Cardiovasc Pharmacother 2016; 2:152-67.
Li J, Franke J, Pribe-Wolferts R, Meder B, Ehlermann P, Mereles D, Andre F, Abdelrazek MA, Merten C, Schweizer PA, Becker R, Katus HA, Thomas D. Effects of b-blocker therapy on electrocardiographic and echocardiographic characteristics of left ventricular noncompaction. Clin Res Cardiol 2015; 104:241-9.
Li J, Maguy A, Duverger JE, Vigneault P, Comtois P, Shi Y, Tardif JC, Thomas D, Nattel S. Induced KCNQ1 autoimmunity accelerates cardiac repolarization in rabbits: potential significance in arrhythmogenesis and antiarrhythmic therapy. Heart Rhythm 2014; 11:2092-100.
Seyler C, Li J, Schweizer PA, Katus HA, Thomas D. Inhibition of cardiac two-pore-domain K+ (K2P) channels by the novel antiarrhythmic drug vernakalant – Comparison with flecainide. Eur J Pharmacol 2014; 724:51-7.
Li J, Seyler C, Wiedmann F, Schmidt C, Schweizer PA, Becker R, Katus HA, Thomas D. Anti-KCNQ1 K+ channel autoantibodies increase IKs current and are associated with QT interval shortening in dilated cardiomyopathy. Cardiovasc Res 2013; 98:496-503.
Korkmaz S, Zitron E, Bangert A, Seyler C, Li S, Hegedues P, Scherer D, Li J, Fink T, Schweizer PA, Giannitsis E, Karck M, Szabó G, Katus HA, Kaya Z. Provocation of an autoimmune response to cardiac voltage-gated sodium channel Nav1.5 induces cardiac conduction defects in rats. J Am Coll Cardiol 2013; 62:340-9.
Li J**, Becker R, Rauch B, Schiele R, Schneider S, Riemer T, Diller F, Gohlke H, Gottwik M, Steinbeck G, Sabin G, Katus HA, Senges J; for the OMEGA study group. Usefulness of heart rate to predict one-year mortality in patients with atrial fibrillation and acute myocardial infarction (from the OMEGA trial). Am J Cardiol 2013; 111:811-5.
Li J*, Goeser S*, Leuschner F, Volz HC, Buss S, Andrassy M, Oettl R, Pfitzer G, Katus HA, Kaya Z. Mucosal tolerance induction in autoimmune myocarditis and myocardial infarction. Int J Cardiol 2013; 162:245-52.
Li J, Warth A, Schnabel P, Schweizer PA, Buss S, Steen H, Becker R, Katus HA, Thomas D. Electrophysiological findings in Fabry cardiomyopathy: mapping the maze of risk stratification. Acta Cardiol 2012; 76:481-5.
Volz HC*, Buss S*, Li J, Goeser S, Andrassy M, Oettl R, Pfitzer G, Katus HA, Kaya Z. Autoimmunity against cardiac troponin I in ischaemia reperfusion injury. Eur J Heart Fail 2011; 10:1052-9.
Li J**, Zitron E, Katus HA, Becker R. Seventh try’s a charm – Ventricular fibrillation terminated by the seventh shock. Circ Arrhythm Electrophysiol 2011; 4:e4-6.
Li J**, Zitron E, Katus HA, Becker R. PMS – Premenstrual storm? An unusual cause of electrical storm in a young woman with vasospastic angina. Clin Res Cardiol 2011; 4:367-71.
Kaya Z, Goeser S, Buss S, Leuschner F, Völkers M, Oettl R, Li J, Zittrich S, Pfitzer G, Rose NR, Katus HA. Identification of cardiac troponin I sequence motifs leading to heart failure by inducing myocardial inflammation and fibrosis. Circ 2008; 118:2063-72.
Leuschner F*, Li J*, Goeser S, Reinhardt L, Oettl R, Bride P, Pfitzer G, Remppis A, Giannitsis E, Katus HA, Kaya Z. Absence of autoantibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction. Eur Heart J 2008; 29:1949-55.
